Interlaced method for treating cancer or a precancerous condition

Details for Australian Patent Application No. 2010256442 (hide)

Owner TAU Therapeutics LLC

Inventors Krouse, Andrew J.; Gray, Lloyd S.; Macdonald, Timothy; Linden, Joel

Agent Davies Collison Cave

Pub. Number AU-A-2010256442

PCT Pub. Number WO2010/141842

Priority 61/184,658 05.06.09 US

Filing date 4 June 2010

Wipo publication date 9 December 2010

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2010/141842 Priority application(s): WO2010/141842

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010256445-Immunoregulatory peptides and methods of use

2010256436-Silicon pen nanolithography